- £2.80bn
- £2.68bn
- £719.15m
- 100
- 25
- 95
- 89
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 669 | 605 | 569 | 642 | 719 |
Cost of Revenue | |||||
Gross Profit | 312 | 284 | 263 | 292 | 339 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 542 | 491 | 463 | 518 | 570 |
Operating Profit | 127 | 113 | 106 | 124 | 149 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 124 | 113 | 106 | 124 | 151 |
Provision for Income Taxes | |||||
Net Income After Taxes | 94.1 | 85.8 | 80.2 | 93.2 | 113 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 94.1 | 85.8 | 80.2 | 93.2 | 113 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 94.1 | 85.8 | 80.2 | 93.2 | 113 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.123 | 0.123 | 0.115 | 0.13 | 0.151 |
Dividends per Share |